scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF00265372 |
P698 | PubMed publication ID | 3240844 |
P50 | author | Antonio Ceriello | Q30347888 |
Dario Giugliano | Q59197360 | ||
P2093 | author name string | R Torella | |
A Quatraro | |||
P Dello Russo | |||
P2860 | cites work | Factors of the hemostatic system in diabetic patients. A survey of controlled studies | Q39768937 |
Preparation of a human factor VII deficient plasma | Q40999623 | ||
“What Is Inherited – What Is Added” Hypothesis for the Pathogenesis of Diabetes Mellitus | Q41528081 | ||
Haemostatic variables associated with diabetes and its complications | Q66971398 | ||
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group | Q66972631 | ||
Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population--II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions | Q69980178 | ||
The fluid phase of coagulation and the accelerated atherosclerosis of diabetes mellitus | Q70973565 | ||
Hyperglycemia and arterial disease | Q70973574 | ||
Haemostatic function and cardiovascular death: early results of a prospective study | Q72423400 | ||
Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity | Q79470428 | ||
P433 | issue | 12 | |
P304 | page(s) | 889-891 | |
P577 | publication date | 1988-12-01 | |
P1433 | published in | Diabetologia | Q5270140 |
P1476 | title | Blood glucose may condition factor VII levels in diabetic and normal subjects. | |
P478 | volume | 31 |
Q44962315 | Activation of Coagulation in Diabetes Mellitus in Relation to the Presence of Vascular Complications |
Q35993115 | Acute hyperglycaemia: a 'new' risk factor during myocardial infarction |
Q40898939 | Admission Glucose Level Predicts In-hospital Mortality in Patients with Acute Pulmonary Embolism Who Were Treated with Thrombolytic Therapy |
Q37453099 | An overview of glycemic control in the coronary care unit with recommendations for clinical management |
Q37997963 | Antithrombotic therapy in patients with acute coronary syndrome and diabetes mellitus |
Q33748127 | Blood glucose as a marker of venous thromboembolism in critically ill children |
Q71993564 | Coagulation Activation in Type 2 Diabetes Mellitus: the Higher Coronary Risk of Female Diabetic Patients |
Q40795448 | Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects |
Q35314944 | Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients |
Q33983641 | Diabetes mellitus and coronary heart disease--from prevention to intervention: Part I. |
Q37496314 | Diabetes, Obesity and Atrial Fibrillation: Epidemiology, Mechanisms and Interventions |
Q93185962 | Effects of glycemic control and hypoglycemia on Thrombus formation assessed using automated microchip flow chamber system: an exploratory observational study |
Q36839933 | Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation |
Q51364256 | Effects of mealtime insulin aspart and bedtime neutral protamine Hagedorn insulin on postprandial coagulation and fibrinolysis in patients with type 2 diabetes. |
Q43571755 | Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: influence of type of diabetes, obesity index, and age. |
Q41675668 | Hemostatic concomitants of syndrome X |
Q37759238 | Hyperglycemia: a prothrombotic factor? |
Q36323852 | Lowering blood glucose during hip surgery does not influence coagulation activation |
Q36382360 | Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions. |
Q26752613 | Options for Controlling Type 2 Diabetes during Ramadan |
Q28087462 | Pathogenesis of diabetic cerebral vascular disease complication |
Q58829366 | Post-meal coagulation activation in diabetes mellitus: the effect of acarbose |
Q36632034 | Postprandial hyperglycaemia and vascular damage--the benefits of acarbose |
Q36645776 | Postprandial insulin resistance as an early predictor of cardiovascular risk. |
Q43572444 | Red wine protects diabetic patients from meal-induced oxidative stress and thrombosis activation: a pleasant approach to the prevention of cardiovascular disease in diabetes |
Q33906474 | Revascularization strategies in patients with diabetes: evolving concepts |
Q45309131 | The Effects of Diet and Insulin Therapy on Coagulation Factor VII, Blood Viscosity, and Platelet Release Proteins in Diabetic Patients with Secondary Sulphonylurea Failure |
Q34292419 | The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus |
Q36904452 | The pathophysiology of cardiovascular disease in diabetes mellitus and the future of therapy |
Q33883730 | The post-prandial state and cardiovascular disease: relevance to diabetes mellitus |
Q37176001 | Venous thromboembolism has the same risk factors as atherosclerosis: A PRISMA-compliant systemic review and meta-analysis |
Search more.